TY - JOUR
T1 - Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management
T2 - A Scientific Statement from the American Heart Association: Endorsed by the International Society for Cardiovascular Infectious Diseases
AU - Baddour, Larry M.
AU - Esquer Garrigos, Zerelda
AU - Rizwan Sohail, M.
AU - Havers-Borgersen, Eva
AU - Krahn, Andrew D.
AU - Chu, Vivian H.
AU - Radke, Connie S.
AU - Avari-Silva, Jennifer
AU - El-Chami, Mikhael F.
AU - Miro, Jose M.
AU - Desimone, Daniel C.
N1 - Publisher Copyright:
© 2024 Lippincott Williams and Wilkins. All rights reserved.
PY - 2024/1/9
Y1 - 2024/1/9
N2 - The American Heart Association sponsored the first iteration of a scientific statement that addressed all aspects of cardiovascular implantable electronic device infection in 2010. Major advances in the prevention, diagnosis, and management of these infections have occurred since then, necessitating a scientific statement update. An 11-member writing group was identified and included recognized experts in cardiology and infectious diseases, with a career focus on cardiovascular infections. The group initially met in October 2022 to develop a scientific statement that was drafted with front-line clinicians in mind and focused on providing updated clinical information to enhance outcomes of patients with cardiovascular implantable electronic device infection. The current scientific statement highlights recent advances in prevention, diagnosis, and management, and how they may be incorporated in the complex care of patients with cardiovascular implantable electronic device infection.
AB - The American Heart Association sponsored the first iteration of a scientific statement that addressed all aspects of cardiovascular implantable electronic device infection in 2010. Major advances in the prevention, diagnosis, and management of these infections have occurred since then, necessitating a scientific statement update. An 11-member writing group was identified and included recognized experts in cardiology and infectious diseases, with a career focus on cardiovascular infections. The group initially met in October 2022 to develop a scientific statement that was drafted with front-line clinicians in mind and focused on providing updated clinical information to enhance outcomes of patients with cardiovascular implantable electronic device infection. The current scientific statement highlights recent advances in prevention, diagnosis, and management, and how they may be incorporated in the complex care of patients with cardiovascular implantable electronic device infection.
KW - AHA Scientific Statements
KW - defibrillators, implantable
KW - diagnosis
KW - echocardiography, transesophageal
KW - endocarditis
KW - infection
UR - http://www.scopus.com/inward/record.url?scp=85182026314&partnerID=8YFLogxK
U2 - 10.1161/CIR.0000000000001187
DO - 10.1161/CIR.0000000000001187
M3 - Article
C2 - 38047353
AN - SCOPUS:85182026314
SN - 0009-7322
VL - 149
SP - E201-E216
JO - Circulation
JF - Circulation
IS - 2
ER -